A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice

European Journal of Immunology

Volumn 40, Issue 9, 2010, Pages 2517-2527

  Wu, Wenhui ^a   Huang, Lu ^a   Mendez, Susana ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Leishmaniasis; Th17; Vaccine

Indexed keywords

BLOCKING ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; LEISHMANIA VACCINE; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CPG ISLAND; DRUG EFFECTS; GENETICS; HELPER CELL; IMMUNOLOGY; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PATHOLOGY; SECRETION (PROCESS); SKIN; VACCINATION;

ANIMALS; ANTIBODIES, BLOCKING; CELL PROLIFERATION; CPG ISLANDS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; LEISHMANIA MAJOR; LEISHMANIASIS VACCINES; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; SKIN; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION;

EID: 77956478102     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040484     Document Type: Article

References (36)

1. Desjeux, P., Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 2004. 27: 305-318.
2. Herwaldt, B. L., Stokes, S. L. and Juranek, D. D., American cutaneous leishmaniasis in U.S. travelers. Ann. Intern. Med. 1993. 118: 779-784.
3. Magill, A. J., Cutaneous leishmaniasis in the returning traveler. Infect. Dis. Clin. N. Am. 2005. 19: 241-266, x-xi.
4. Aebischer, T., Moody, S. F. and Handman, E., Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 1993. 61: 220-226.
5. Bogdan, C., Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell. Microbiol. 2008. 10: 1221-1234.
6. Mendez, S., Reckling, S. K., Piccirillo, C. A., Sacks, D. and Belkaid, Y., Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 2004. 200: 201-210.
7. Nicolas, L., Sidjanski, S., Colle, J. H. and Milon, G., Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice. Infect. Immun. 2000. 68: 6561-6566.
8. Okwor, I. and Uzonna, J., Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies. Immunol. Res. 2008. 41: 123-136.
9. Momeni, A. Z. and Aminjavaheri, M., Treatment of recurrent cutaneous Leishmaniasis. Int. J. Dermatol. 1995. 34: 129-133.
10. Mendez, S., Tabbara, K., Belkaid, Y., Bertholet, S., Verthelyi, D., Klinman, D., Seder, R. A. and Sacks, D. L., Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous leishmaniasis but maintains its potency and durability. Infect. Immun. 2003. 71: 5121-5129.
11. Wu, W., Weigand, L., Belkaid, Y. and Mendez, S., Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides. Eur. J. Immunol. 2006. 36: 3238-3247.
12. Laabs, E. M., Wu, W. and Mendez, S. M., Vaccination with live Leishmania major and CpG DNA promotes IL-2 production by dermal dendritic cells and NK cell activation. Clin. Vaccine Immunol. 2009. 16: 1601-1606.
13. Belkaid, Y., Kamhawi, S., Modi, G., Valenzuela, J., Noben-Trauth, N., Rowton, E., Ribeiro, J. and Sacks, D. L., Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J. Exp. Med. 1998. 188: 1941-1953.
14. Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon, G. and Sacks, D., A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 2000. 165: 969-977.
15. Chen, Z. and O'Shea, J. J., Th17 cells: a new fate for differentiating helper T cells. Immunol. Res. 2008. 41: 87-102.
16. Suffia, I., Reckling, S. K., Salay, G. and Belkaid, Y., A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 2005. 174: 5444-5455.
17. Dubin, P. J. and Kolls, J. K., Th17 cytokines and mucosal immunity. Immunol. Rev. 2008. 226: 160-171.
18. Khader, S. A., Gaffen, S. L. and Kolls, J. K., Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol. 2009. 2: 403-411.
19. Cooper, A. M. and Khader, S. A., The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 2008. 226: 191-204.
20. Pitta, M. G., Romano, A., Cabantous, S., Henri, S., Hammad, A., Kouriba, B., Argiro, L. et al., IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J. Clin. Invest. 2009. 119: 2379-2387.
21. Bacellar, O., Faria, D., Nascimento, M., Cardoso, T. M., Gollob, K. J., Dutra, W. O., Scott, P. and Carvalho, E. M., Interleukin 17 production among patients with American cutaneous leishmaniasis. J. Infect. Dis. 2009. 200: 75-78.
22. Lopez Kostka, S., Dinges, S., Griewank, K., Iwakura, Y., Udey, M. C. and von Stebut, E., IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J. Immunol. 2009. 182: 3039-3046.
23. Anderson, C. F., Stumhofer, J. S., Hunter, C. A. and Sacks, D., IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J. Immunol. 2009. 183: 4619-4627.
24. Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M. and Sacks, D. L., CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002. 420: 502-507.
25. Kryczek, I., Wei, S., Zou, L., Altuwaijri, S., Szeliga, W., Kolls, J., Chang, A. and Zou, W., Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 2007. 178: 6730-6733. (Pubitemid 46847396)
26. Eid, R. E., Rao, D. A., Zhou, J., Lo, S. F., Ranjbaran, H., Gallo, A., Sokol, S. I. et al., Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009. 119: 1424-1432.
27. Leung, S., Liu, X., Fang, L., Chen, X., Guo, T. and Zhang, J., The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell. Mol. Immunol. 2010. 7: 182-189.
28. Damsker, J. M., Hansen, A. M. and Caspi, R. R., Th1 and Th17 cells: adversaries and collaborators. Ann. N. Y. Acad. Sci. 2010. 1183: 211-221.
29. Dardalhon, V., Korn, T., Kuchroo, V. K. and Anderson, A. C., Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 2008. 31: 252-256.
30. Peck, A. and Mellins, E. D., Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 2010. 129: 147-153.
31. Ribeiro-Gomes, F. L., Moniz-de-Souza, M. C., Alexandre-Moreira, M. S., Dias, W. B., Lopes, M. F., Nunes, M. P., Lungarella, G. and DosReis, G. A., Neutrophils activate macrophages for intracellular killing of Leishmania major through recruitment of TLR4 by neutrophil elastase. J. Immunol. 2007. 179: 3988-3994.
32. Peters, N. C., Egen, J. G., Secundino, N., Debrabant, A., Kimblin, N., Kamhawi, S., Lawyer, P. et al., In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 2008. 321: 970-974.
33. Ribeiro-Gomes, F. L., Moniz-de-Souza, M. C., Borges, V. M., Nunes, M. P., Mantuano-Barradas, M., D'Avila, H., Bozza, P. T. et al., Turnover of neutrophils mediated by Fas ligand drives Leishmania major infection. J. Infect. Dis. 2005. 192: 1127-1134.
34. Guimaraes-Costa, A. B., Nascimento, M. T., Froment, G. S., Soares, R. P., Morgado, F. N., Conceicao-Silva, F. and Saraiva, E. M., Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps. Proc. Natl. Acad. Sci. USA 2009. 106: 6748-6753.
35. El Kebir, D., Jozsef, L. and Filep, J. G., Neutrophil recognition of bacterial DNA and Toll-like receptor 9-dependent and -independent regulation of neutrophil function. Arch. Immunol. Ther. Exp. (Warsz) 2008. 56: 41-53.
36. Spath, G. F. and Beverley, S. M., A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 2001. 99: 97-103.